Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keyhole limpet hemocyanin (KLH) is a large, multisubunit, oxygen-carrying metalloprotein found in the hemolymph of the giant keyhole limpet (*Megathura crenulata*). It is used as an immunostimulant and carrier protein in biomedical applications, particularly in vaccine development. KLH enhances the immune response to weakly antigenic substances and has been investigated in cancer immunotherapy. Two major isoforms exist: KLH1/KLH-A and KLH2/KLH-B, which differ slightly in their structure and oxygen binding affinity.
Acts as an immune stimulant and carrier protein, enhancing the immune response to weakly antigenic substances. In cancer vaccines, it helps to stimulate an immune response against tumor-associated antigens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keyhole Limpet Hemocyanin (KLH).